• SENSEX 80,737.51
    -636.24 (--0.78%)
  • BANKNIFTY 55,599.95
    -303.45 (--0.54%)
  • Yes Bank
    20.77 16.02(%)
  • Vodafone Idea
    6.74 6.46(%)
  • Aptus Value Hou.
    305.00 267.75(%)
  • TCS
    3,399.40 3,060.25(%)
  • Larsen & Toubro
    3,617.00 2,967.65(%)
  • Eternal Ltd
    236.80 146.85(%)
  • Zinka Logistics
    451.35 548.00(%)
  • M & M
    3,065.15 3,276.30(%)
  • HDFC Bank
    1,920.00 1,452.85(%)
  • Garden Reach Sh.
    3,188.75 3,143.00(%)
  • Cochin Shipyard
    2,049.70 2,977.10(%)
  • Reliance Industr
    1,403.00 1,115.55(%)
  • Suzlon Energy
    67.95 45.13(%)
  • Kotak Mah. Bank
    2,033.40 1,602.20(%)
  • Brainbees Solut.
    393.00 734.25(%)
  • Infosys
    1,535.35 1,307.10(%)
  • ICICI Bank
    1,431.75 1,051.50(%)
  • Bharti Airtel
    1,831.75 1,224.50(%)
  • Reliance Power
    58.50 23.26(%)
  • Axis Bank
    1,175.00 934.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ind-Swift Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 7927.0
  • ISIN : INE915B01019
88.19 6 (7.42%)
  • As on 03 Jun 2025 (EOD)

  • Today’s Low

    81.90

  • Today’s High

    92.15

  • Open

    82.35

  • Perv Close

    82.10

  • 52W Low

    68.72

  • 52W High

    186.00

Key Indicators

  • P/E(TTM)

    5.96

  • Mar.Cap (₹Cr.)

    534.60

  • Div & Yield %

    0.00

  • Book Value(₹)

    169.26

  • Debt-Equity Ratio

    7.42

  • AGM Date

    03-Jun-2025

  • EPS

    14.80

  • P/E Ratio

    5.96

Financials Ratios

  • Debt-Equity Ratio

    0.61

  • Mar.Cap (₹Cr.)

    534.60

  • RONW (%)

    19.32

  • ROCE (%)

    20.71

Score Board

  • Equity (₹ in Cr.)

    60.62

  • BV (₹)

    169.30

  • Sales( ₹ in Cr.)

    1,227.32

  • NP (in Cr.)

    137.89

  • NP Var(%)

    147.0

  • Div%

    0.0

  • CPS (₹)

    31.50

  • EPS (₹)

    22.70

  • Traded Value (₹ in Lakhs)

    497.68

  • 52 Week High

    186.00

  • 52 Week Low

    68.72

  • Price BSE

    82.0

  • Price NSE

    82.00

  • Market Capital( in Cr.)

    497.68

  • P/C Ratio

    2.60

  • P/E Ratio

    3.60

  • Price Vs.BV

    22.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 1,227.32 1,151.96 988.09 856.58 751.84 724.43
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,227.32 1,151.96 988.09 856.58 751.84 724.43
Other Income 431.90 33.28 42.50 23.13 36.02 129.94
Stock Adjustments -37.07 12.34 39.47 2.48 12.44 14.20
Total Income 1,622.15 1,197.58 1,070.06 882.19 800.30 868.57
EXPENDITURE :            
Raw Materials 586.51 629.18 537.62 427.47 391.29 397.43
Power and Fuel Cost 61.43 76.07 58.40 37.31 34.65 37.44
Employee Cost 148.88 132.70 124.62 104.17 100.38 88.94
Other Manufacturing Expenses 42.34 38.53 36.51 28.76 25.73 25.70
Selling and Administration Expenses 77.92 63.98 62.17 78.98 69.66 63.48
Miscellaneous Expenses 23.20 28.40 16.22 1.87 0.62 0.39
Employee Benefit Expenses 148.88 132.70 124.62 104.17 100.38 88.94
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 940.28 968.85 835.54 678.56 622.32 613.39
Operating Profit 681.87 228.73 234.52 203.63 177.98 255.18
Interest 51.10 92.17 95.55 100.22 107.48 92.20
Gross Profit 630.77 136.56 138.97 103.41 70.50 162.98
Depreciation 53.30 57.36 130.97 87.29 90.06 104.05
Profit Before Tax 577.47 79.20 8.00 16.12 -19.56 58.93
Current Tax 169.92 13.36 24.62 11.04 0.41 3.35
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -10.84 23.36 -10.92 9.48 0.82 16.99
Reported Net Profit 418.39 42.47 -5.71 -4.40 -20.79 38.58
Extraordinary Items 280.50 -13.39 -3.13 0.00 0.07 65.91
Adjusted Net Profit 137.89 55.86 -2.58 -4.40 -20.86 -27.33
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -3.96
P & L Balance brought forward -37.69 -80.16 -74.45 -70.05 -49.26 -83.89
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 380.70 -37.69 -80.16 -74.45 -70.05 -49.26
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 70.81 7.10 -0.95 -0.74 -3.48 7.99
Earnings Per Share(Adj)-Unit Curr 70.81 7.10 -0.95 -0.74 -3.48 7.99
Book Value 156.08 82.26 72.91 71.55 70.15 72.58
Book Value(Adj)-Unit Curr 156.08 82.26 72.91 71.55 70.15 72.58

Shareholding Pattern

  • Promoter Group

    40.94%

  • Public Share Holding

    59.06%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 22,327,507 36.83 22,327,507 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,491,276 4.11 2,491,276 17
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 24,818,783 40.94 24,818,783 18
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,860,970 3.07 1,860,970 7
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 554,040 0.91 554,040 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,415,010 3.98 2,415,010 10
2] Non Institution
Bodies Corporate 8,479,631 13.99 8,469,831 157
Clearing Members 131,960 0.22 131,960 17
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 558,150 0.92 558,150 399
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 932,410 1.54 932,410 680
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 12,957,248 21.37 12,957,248 126
Individuals holding nominal share capital up to Rs. 1 lakh 9,843,556 16.24 9,712,206 26,694
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 390,435 0.64 390,435 3
Sub Total 33,385,067 55.07 33,243,917 28,089
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 60,618,860 100.00 60,477,710 28,117

Company Background

Ind-Swift Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Ind-Swift Laboratories Ltd
  • BSE Code : 7927.0
  • ISIN : INE915B01019

  • Incorporation Year

    1995

  • Registered Office

    SCO 850 Shivalik Enclave
    NAC Manimajra, Chandigarh,
    Chandigarh-160101

  • Telephone

    91-0172-5061850/2730920

  • FAX

    91-0172-2730504/2736294

  • Chairman

    N R Munjal

  • Managing Director

    N R Munjal

  • Company Secretary

    Pradeep Verma

  • Auditor

    Avishkar Singhal & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Alankit Assignments Ltd
    205/208,
    Anarkali Market,Jhandewalan Extn
    Mumbai - New Delhi - 110055

Ind-Swift Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ind-Swift Labs. 88.21 1,272.63 1,227.32 1.48 20.55
Abbott India 31,061.15 6,097.18 5,848.91 46.66 44.71
Astrazeneca Phar 9,334.25 1,330.33 1,295.53 201.60 33.26
P & G Health Ltd 5,742.35 1,166.89 1,151.26 37.95 39.76
Glaxosmi. Pharma 3,223.65 3,530.73 3,407.25 59.42 44.44
Cipla 1,472.80 17,645.00 16,574.34 23.06 20.10
Amrutanjan Healt 730.95 437.58 421.23 41.58 20.84
Fermenta Biotec. 324.00 315.24 307.09 14.11 4.10
Guj. Themis Bio. 306.40 174.19 169.82 68.39 44.82
Bliss GVS Pharma 133.00 638.96 605.46 20.31 11.19
Ambalal Sarabhai 37.52 11.70 3.81 34.74 1.92